Fulgent Genetics's total assets for Q4 2024 were $1.22B, a decrease of -1.12% from the previous quarter. FLGT total liabilities were $90.81M for the fiscal quarter, a -8.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.